ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,421,304, issued on Sept. 23, was assigned to Amgen Inc. (Thousand Oaks, Calif.).
"Method for inhibiting bone resorption" was invented by Ian Desmond Padhi (Newbury Park, Calif.) and Graham Richard Jang (Santa Monica, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention is directed to a method of inhibiting bone resorption. The method comprises administering to a human an amount of sclerostin inhibitor that reduces a bone resorption marker level for at least 2 weeks. The invention also provides a method of monitoring anti-sclerostin therapy comprising measuring one or more bone resorption marker levels, administering a sclerostin binding ...